Abstract
THE PATIENTS with advanced cancers of the head and neck remain a difficult palliative problem for the oncologist. Their systemic metastases develop relatively late in spite of the locally extensive disease and often the adjacent tissues will tolerate no additional radiation therapy; and the tumor distribution is such that neurosurgical procedures have little or nothing to offer for pain relief. This study evaluates the role of intraarterial infusion chemotherapy in such advanced head and neck cancer patients in terms of pain relief, tumor regression, and operability after infusion therapy. Materials and Methods Eleven patients with advanced head and neck tumors were given 15 courses of intra-arterial infusion chemotherapy. Their ages ranged from 18 to 81 years, their mean age being 49 years. Nine of the patients were male, two were female. Nine patients had squamous cell carcinomas of the head and neck region, one patient had a malignant melanoma of
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
